idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
idw - Informationsdienst
Wissenschaft
Normally, the immune system recognizes and eliminates abnormal cells. However, cancer cells can develop strategies to evade this control: they block defense mechanisms or send inhibitory signals. In this way, tumors can grow unchecked. In a collaborative study, research teams from Germany, the United Kingdom, and Hungary have tackled this challenge by creating artificial tumor models in which synthetic cells mimic immune responses. The study has now been published in the journal Nature Communications.
The researchers designed synthetic cells to combine with real cancer cells into three-dimensional mini-tumors, known as tumoroids. This combination of living and synthetic material relies on the cells’ natural ability to self-organize. The resulting structures depend on factors such as cell adhesion strength and the “softness” of the cell surface. It turned out that synthetic cells work particularly well when coated with a thin layer of fat, resembling the membrane of natural cells. This allows the creation of artificial tumor-immune environments and the simulation of typical signals that immune cells normally produce. Using this approach, the team can study how tumors evade the immune system - without the need for real immune cells.
“With our model, we can track how tumors trick and block the immune system,” explains Dr. Oskar Staufer from the INM – Leibniz Institute for New Materials in Saarbrücken. “In the case of pancreatic cancer, a particularly aggressive type, we were able to discover a new mechanism by which the cancer selectively disables immune cells.” The study also shows that the surface properties and other physical characteristics of synthetic cells are crucial for the correct formation of tumor models. This insight opens the door to intentionally designing artificial tumor environments in the future. Looking ahead, Nils Piernitzki, first author of the study, says: “So far, we have focused on a simple experimental setup to evaluate the potential of the model. Next, we aim to replicate the tumor environment in the human body as realistically as possible.”
In the long term, this method could not only advance cancer research but also create new approaches for combining “living” and “non-living” components in innovative medical materials.
Dr. Oskar Staufer
INM - Leibniz Institute for New Materials
Head Research Group Immuno Materials
Oskar.staufer@leibniz-inm.de
Phone: +(0)681 9300 281
Piernitzki, N., Gao, N., Gasparoni, G. et al. Self-assembly of hybrid 3D cultures by integrating living and synthetic cells. Nat Commun 16, 11073 (2025).
https://doi.org/10.1038/s41467-025-66789-3
Cancer cells (red and blue) bind closely to a synthetic immune cell (green), forming a hybrid cell c ...
Quelle: Nils Piernitzki
Copyright: Nils Piernitzki/INM
Merkmale dieser Pressemitteilung:
Journalisten, Wissenschaftler
Biologie, Chemie, Medizin, Werkstoffwissenschaften
überregional
Wissenschaftliche Publikationen
Englisch
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
